The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Pandemic Influenza Vaccine Market Research Report 2025
Synopsis
The global Pandemic Influenza Vaccine market was valued at US$ 7829.8 million in 2023 and is anticipated to reach US$ 11790 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
This report aims to provide a comprehensive presentation of the global market for Pandemic Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pandemic Influenza Vaccine.
Report Scope
The Pandemic Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pandemic Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pandemic Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pandemic Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pandemic Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global Pandemic Influenza Vaccine market was valued at US$ 7829.8 million in 2023 and is anticipated to reach US$ 11790 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
Global key players of Pandemic Influenza Vaccine include Sanofi, CSL and GSK, etc. The top five players hold a share about 75%. North America is the largest market, has a share about 50%.
This report aims to provide a comprehensive presentation of the global market for Pandemic Influenza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pandemic Influenza Vaccine.
Report Scope
The Pandemic Influenza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Pandemic Influenza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pandemic Influenza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Sanofi
CSL
GSK
Viatris
AstraZeneca
Hualan Bio
Changchun Institute of Biological
Sinovac
BCHT
Jiangsu GDK
KM Biologics
Segment by Type
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Segment by Application
6 Months to 3 Years
> 3 Years
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Pandemic Influenza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Pandemic Influenza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Pandemic Influenza Vaccine Market Overview
1.1 Product Overview and Scope of Pandemic Influenza Vaccine
1.2 Pandemic Influenza Vaccine Segment by Type
1.2.1 Global Pandemic Influenza Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Trivalent Influenza Vaccine
1.2.3 Quadrivalent Influenza Vaccine
1.3 Pandemic Influenza Vaccine Segment by Application
1.3.1 Global Pandemic Influenza Vaccine Market Value by Application: (2024-2030)
1.3.2 6 Months to 3 Years
1.3.3 > 3 Years
1.4 Global Pandemic Influenza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Pandemic Influenza Vaccine Revenue 2019-2030
1.4.2 Global Pandemic Influenza Vaccine Sales 2019-2030
1.4.3 Global Pandemic Influenza Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Pandemic Influenza Vaccine Market Competition by Manufacturers
2.1 Global Pandemic Influenza Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Pandemic Influenza Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Pandemic Influenza Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Pandemic Influenza Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Pandemic Influenza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Pandemic Influenza Vaccine, Product Type & Application
2.7 Pandemic Influenza Vaccine Market Competitive Situation and Trends
2.7.1 Pandemic Influenza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Pandemic Influenza Vaccine Players Market Share by Revenue
2.7.3 Global Pandemic Influenza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Pandemic Influenza Vaccine Retrospective Market Scenario by Region
3.1 Global Pandemic Influenza Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Pandemic Influenza Vaccine Global Pandemic Influenza Vaccine Sales by Region: 2019-2030
3.2.1 Global Pandemic Influenza Vaccine Sales by Region: 2019-2024
3.2.2 Global Pandemic Influenza Vaccine Sales by Region: 2025-2030
3.3 Global Pandemic Influenza Vaccine Global Pandemic Influenza Vaccine Revenue by Region: 2019-2030
3.3.1 Global Pandemic Influenza Vaccine Revenue by Region: 2019-2024
3.3.2 Global Pandemic Influenza Vaccine Revenue by Region: 2025-2030
3.4 North America Pandemic Influenza Vaccine Market Facts & Figures by Country
3.4.1 North America Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Pandemic Influenza Vaccine Sales by Country (2019-2030)
3.4.3 North America Pandemic Influenza Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Pandemic Influenza Vaccine Market Facts & Figures by Country
3.5.1 Europe Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Pandemic Influenza Vaccine Sales by Country (2019-2030)
3.5.3 Europe Pandemic Influenza Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Pandemic Influenza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Pandemic Influenza Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Pandemic Influenza Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Pandemic Influenza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Pandemic Influenza Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Pandemic Influenza Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Pandemic Influenza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Pandemic Influenza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Pandemic Influenza Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Pandemic Influenza Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Pandemic Influenza Vaccine Sales by Type (2019-2030)
4.1.1 Global Pandemic Influenza Vaccine Sales by Type (2019-2024)
4.1.2 Global Pandemic Influenza Vaccine Sales by Type (2025-2030)
4.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Pandemic Influenza Vaccine Revenue by Type (2019-2030)
4.2.1 Global Pandemic Influenza Vaccine Revenue by Type (2019-2024)
4.2.2 Global Pandemic Influenza Vaccine Revenue by Type (2025-2030)
4.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Pandemic Influenza Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Pandemic Influenza Vaccine Sales by Application (2019-2030)
5.1.1 Global Pandemic Influenza Vaccine Sales by Application (2019-2024)
5.1.2 Global Pandemic Influenza Vaccine Sales by Application (2025-2030)
5.1.3 Global Pandemic Influenza Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Pandemic Influenza Vaccine Revenue by Application (2019-2030)
5.2.1 Global Pandemic Influenza Vaccine Revenue by Application (2019-2024)
5.2.2 Global Pandemic Influenza Vaccine Revenue by Application (2025-2030)
5.2.3 Global Pandemic Influenza Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Pandemic Influenza Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Sanofi
6.1.1 Sanofi Corporation Information
6.1.2 Sanofi Description and Business Overview
6.1.3 Sanofi Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Sanofi Pandemic Influenza Vaccine Product Portfolio
6.1.5 Sanofi Recent Developments/Updates
6.2 CSL
6.2.1 CSL Corporation Information
6.2.2 CSL Description and Business Overview
6.2.3 CSL Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CSL Pandemic Influenza Vaccine Product Portfolio
6.2.5 CSL Recent Developments/Updates
6.3 GSK
6.3.1 GSK Corporation Information
6.3.2 GSK Description and Business Overview
6.3.3 GSK Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 GSK Pandemic Influenza Vaccine Product Portfolio
6.3.5 GSK Recent Developments/Updates
6.4 Viatris
6.4.1 Viatris Corporation Information
6.4.2 Viatris Description and Business Overview
6.4.3 Viatris Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Viatris Pandemic Influenza Vaccine Product Portfolio
6.4.5 Viatris Recent Developments/Updates
6.5 AstraZeneca
6.5.1 AstraZeneca Corporation Information
6.5.2 AstraZeneca Description and Business Overview
6.5.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 AstraZeneca Pandemic Influenza Vaccine Product Portfolio
6.5.5 AstraZeneca Recent Developments/Updates
6.6 Hualan Bio
6.6.1 Hualan Bio Corporation Information
6.6.2 Hualan Bio Description and Business Overview
6.6.3 Hualan Bio Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Hualan Bio Pandemic Influenza Vaccine Product Portfolio
6.6.5 Hualan Bio Recent Developments/Updates
6.7 Changchun Institute of Biological
6.6.1 Changchun Institute of Biological Corporation Information
6.6.2 Changchun Institute of Biological Description and Business Overview
6.6.3 Changchun Institute of Biological Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Changchun Institute of Biological Pandemic Influenza Vaccine Product Portfolio
6.7.5 Changchun Institute of Biological Recent Developments/Updates
6.8 Sinovac
6.8.1 Sinovac Corporation Information
6.8.2 Sinovac Description and Business Overview
6.8.3 Sinovac Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Sinovac Pandemic Influenza Vaccine Product Portfolio
6.8.5 Sinovac Recent Developments/Updates
6.9 BCHT
6.9.1 BCHT Corporation Information
6.9.2 BCHT Description and Business Overview
6.9.3 BCHT Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 BCHT Pandemic Influenza Vaccine Product Portfolio
6.9.5 BCHT Recent Developments/Updates
6.10 Jiangsu GDK
6.10.1 Jiangsu GDK Corporation Information
6.10.2 Jiangsu GDK Description and Business Overview
6.10.3 Jiangsu GDK Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Jiangsu GDK Pandemic Influenza Vaccine Product Portfolio
6.10.5 Jiangsu GDK Recent Developments/Updates
6.11 KM Biologics
6.11.1 KM Biologics Corporation Information
6.11.2 KM Biologics Pandemic Influenza Vaccine Description and Business Overview
6.11.3 KM Biologics Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 KM Biologics Pandemic Influenza Vaccine Product Portfolio
6.11.5 KM Biologics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Pandemic Influenza Vaccine Industry Chain Analysis
7.2 Pandemic Influenza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Pandemic Influenza Vaccine Production Mode & Process
7.4 Pandemic Influenza Vaccine Sales and Marketing
7.4.1 Pandemic Influenza Vaccine Sales Channels
7.4.2 Pandemic Influenza Vaccine Distributors
7.5 Pandemic Influenza Vaccine Customers
8 Pandemic Influenza Vaccine Market Dynamics
8.1 Pandemic Influenza Vaccine Industry Trends
8.2 Pandemic Influenza Vaccine Market Drivers
8.3 Pandemic Influenza Vaccine Market Challenges
8.4 Pandemic Influenza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
